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ABSTRACT  Stem cells capable of long-term proliferation and differentiation into different cell types may be a promising source of cells for  regenerative medicine. 
recently, much attention has been paid to fetal stem cells, among which are cells from amniotic fluid (AF). We have isolated amniotic stem cells from 3 AF samples.   
Flow cytometry, rt-Pcr and immunohistochemistry have shown that these cells express mesenchymal (cD90, cD73, cD105, cD13, cD29, cD44, and cD146), 
neural (β3-tubulin, nestin, and Pax6), epithelial (keratin 19 and p63) markers and also markers of pluripotency (Oct4, Nanog, and Rex-1). transplantation of the 
cells to nude mice does not lead to tumor formation. thus, putative stem/progenitor cells from AF are capable of long-term proliferation in vitro and the profile of 
gene expression led us to speculate that they have greater differentiation potential than mesenchymal stem cells and may be useful for cell therapy.
Keywords: amniotic fluid, cell culture, epithelial markers, mesenchymal stem cells, neural markers, stem cells.
Abbreviations: amniotic fluid (AF); mesenchymal stem cells (MScs); embryonic stem cells (eScs).
INTRODuCTION
AF has been used in prenatal diagnosis of genetic diseases 
for more than 70 years (Baranov and Kuznetsova, 2007). 
It contains a heterogeneous population of cells, which in-
cludes cells from fetal skin, respiratory, digestive, and uri-
nary tracts, as well as cells from the amniotic membrane. 
Most of these cells are differentiated and have a low pro-
liferative potential (Siddiqyi and Atala, 2004; tsai et al., 
2006). recent data seem to indicate that AF contains cells 
which can proliferate for extended periods of time and 
can differentiate in vitro into different cell types. Based 
on the fact that these cells express such markers as cD73, 
cD90, cD105, cD44, and cD29, several researchers con-
sider them as MScs (tsai et al., 2004; Sessarego et al., 2008). 
Interestingly, cells isolated from AF express neural mark-
ers, such as nestin, β3-tubulin, GFAP, neFH, as well as 
several markers of eScs, such as SSeA-4, Oct4, and nanog 
(Prusa et al., 2003; Siddiqyi and Atala, 2004; tsai et al., 
2006). these cells exhibit osteogenic, adipogenic, myogenic 
and neural differentiation; they can also differentiate into 
hepatocytes and endothelial cells (tsai et al., 2004; Delo et 
al., 2006; tsai et al., 2006; De coppi et al., 2007; Perin et al., 
2008; You et al., 2008; Zheng et al., 2008). thus, the avail-
able data suggest, on the one hand, that cells from AF are 
intermediate in their differentiation potential (between 
embryonic and adult stem cells) and, on the other hand, 
the possibility that AF culture contains several distinct cell 
types (i.e. population heterogeneity). In order to assess this 
possibility, a further detailed investigation of the popula-
tion structure is needed, which implies extensive data on 
the gene expression profile. 
Obtaining AF is a very simple and safe procedure; the 
cells from AF are relatively easy to isolate and cultivate, and 
they show little immunogenicity and higher proliferative 
potential than that of adult stem cells. Also, AF cells can dif-
ferentiate into the derivatives of the three germ layers and 
do not form teratomas after transplantation. All these facts 
suggest that AF can be an alternative source of stem cells for 
cell therapy (Prusa et al., 2003; Delo et al., 2006; trounson, 
2007). Also, the possibility of obtaining cells which express 
several pluripotency markers evade the ethical concerns 
arising in human eScs research. 
the goal of this study was to investigate the prolifera-
tive potential of cells isolated from AF and to analyze the 
expression of certain tissue-specific genes and stem cell 
markers. 
MATERIALS AND METhODS
AF CELL CuLTuRE 
Samples of AF (10 ml) were obtained from three donors via 
amniocentesis performed at 16–20 weeks of pregnancy in 
Snegirev Obstetrics and Gynaecology clinic, Moscow. the 
cells were collected by centrifugation (10 min, 1100 rpm) 
and cultured in α-MeM medium (Gibco, united States) sup-
plemented with 15% eS-FBS (Hyclone, united States), 1% 
glutamine (Invitrogen, united States), 18% chang B and 2% 
chang c (Irvine Scientific, united States), and 1% penicil-
lin/streptomycin (Sigma, united States) at 37 оС with 5% 
humidified СО2. cells were replated  at 1:3 every 2nd or 3rd 
day, when they grew to confluence. 
FLOW CYTOMETRY 
expression of the surface antigens in AF cells (passage 7) 
was assessed using a flow cytometer (Becton Dickinson 
FAcScalibur, united States). the cells were trypsinzed 
and stained with fluorescein isothiocyanate- (FItc) or 
phycoerythrin- (Pe) conjugated antibodies against cD13, 
cD29, cD44, cD106, cD73, cD54, cD45, cD34, cD146, 
cD90, cD105, cD71, HLA-A,B,c, and HLA-Dr,DP,DQ (BD 
Pharmingen, united States). FItc- or Pe-conjugated im-
munoglobulins of the same isotype were used as controls. reSeArcH ArtIcLeS
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Mouse antibodies against keratin 19 (Millipore, united 
States) with secondary Alexa Fluor 488 (Molecular Probes, 
united States) antibodies were used to assay keratin expres-
sion. Staining without primary antibodies and isotypic con-
trols were also performed. 
RT-PCR 
total rnA extraction was performed with trI® reagent 
(Sigma, united States) in accordance with the manufactur-
er’s protocol. mrnA was isolated by using magnetic beads 
(Sileks, russia). the first cDnA strand was synthesized with 
the M-MLV reverse transcriptase (Sileks, russia). cDnA li-
braries were normalized to the housekeeping gene rPL19. 
the Pcr primers were constructed with DnAStar software 
and located in different exons. Information on the structure of 
the studied genes was obtained from the national center for 
Biotechnology Information (ncBI, GeneBank, united States). 
Primer sequences are listed in table 1. Pcr with specific 
primers was performed with coloredtaq-polymerase (Si-
leks, russia) on a Mastercycler (eppendorf, Germany). Pcr 
fragments were separated by electrophoresis in 1% agarose 
gels and analyzed on a uV gel analyzer (®BIO rAD, united 
States).
IMMuNOhISTOChEMISTRY 
cells for immunohistochemistry were taken at the 11th 
passage, fixed with 4% paraformaldehyde and incubated 
overnight at +4оС with antibodies against cD34 (mouse, 
1:200, Millipore, united States), cD105 (mouse, 1 : 50; Mil-
lipore, united States), cD49d (mouse, 1 : 50, Millipore, unit-
ed States), StrO-1 (rabbit, 1 : 100, r&D Systems, united 
States), keratin 14 (mouse, 1:20, novocastra, Germany), kera-
tin 19 (mouse, 1 : 50; Millipore, united States), р63 (mouse, 
1 : 50; BD Pharmingen, united States), β3-tubulin (mouse, 
1:300, Millipore, united States), nF (neurofilament) (mouse, 
1:10, Icn, united States), Pax6 (mouse, 1:100, Millipore, 
united States). After that, the cells were washed with PBS 
and incubated with secondary Alexa Fluor 488 or Alexa Flu-
or 546 antibodies (Molecular Probes, united States) at room 
temperature for 1 h. cell nuclei were stained with DAPI 
(VectASHIeLD mounting medium for fluorescence with 
DAPI, Vector Laboratories, united States).
IMMuNODEFICIENT ANIMAL TRANSPLANTATION  
In order to study the ability of AF cells to form teratomas, im-
munodeficient nude mice were used (Pushino animal nurs-
ery). the animals were subcutaneously injected with 3 × 106 
5th passage cells  suspended in 100 microliters of serum-free 
α-MeM medium (suspension concentration 30 × 106 cells/ml). 
control animals were injected with 100 microliters of sus-
pension of 2nd passage stem cells from human adipose tissue 
(45 × 106 cells/ml) (negative control) and 100 microliters of 
65th passage mouse eScs suspension  (20 × 106 cells/ml) (posi-
tive control). each group consisted of three animals. Animals 
were withdrew from the experiment when tumors were 
detected (positive control) or 11 weeks after injection (ex-
perimental group and negative control). tumors and animal 
organs (liver, kidney, spleen, heart, lung, and testicle) were 
analyzed histologically. 
RESuLTS AND DISCuSSION
AF CELL CuLTuRE 
three samples of AF from three donors were used in this 
study. cultivation was performed in 24-well plates in chang 
medium, following the previously described protocol (De 
coppi et al., 2007) with modifications. 
centrifugation of AF yielded a heterogeneous population 
of cells, most of which were flat epithelial cells. Small round 
cells were a minority. the flat epithelial cells did not adhere 
to plastic and were eliminated from the culture after the first 
medium change on day 5-7. However, round cells did adhere 
to plastic and formed small colonies differing in size and mor-
phology (Fig. 1). Most colonies consisted of fibroblastic cells; 
however some consisted of epithelioid cells. After the first 
medium change, the fibroblastic cell colonies started to prolif-
erate actively, while the colonies with epithelioid cells did not 
change noticeably. Four to six days after the medium change, 
when the cells formed a subconfluent layer, the culture was 
replated; this did not lead to the formation of colonies. cells 
distributed evenly on the bottom of the well and grew to 
confluence in 2–3 days. After passaging, the culture com-
prising only fibroblastic and epithelioid cells were no longer 
observed. 
а b c 200 µm 200 µm 200 µm
Fig. 1. AF cells in culture.  (а) Primary fibroblastic cell colony on day 9 of culture. (b) Primary epithelioid cell colony on day 9 of culture. (c) Cells grew 
to confluence in the 8th-passage culture. (а, b, c) Light field100 | ActA nAturAe |  № 2 2009
reSeArcH ArtIcLeS
three groups of AF cells may be distinguished according 
to their morphology: epithelioid, amniotic fluid-specific, and 
fibroblastic cells (Prusa and Hengstschlager, 2002; tsai et 
al., 2004). the first group and the second one appear at the 
beginning of cultivation, and the third one appears later. 
the epithelioid cells quickly disappear, while the other two 
types persist in the culture. Many authors believe that the 
fibroblastic cells are stem cells and, taking into account the 
expression of mesenchymal markers and the spectrum of 
possible differentiations, place them into the MScs category. 
However, other cells besides the fibroblastic cells can re-
main in the culture. these amniotic fluid-specific cells pro-
duce estrogen, progesterone, and chorionic gonadotropin. 
It seems that these cells originate from the trophoblast and 
the amniotic membrane. thus, the question of amniotic stem 
cells origin is still unresolved (Prusa and Hengstschlager, 
2002; tsai et al., 2004).
It is worth noting that we analyzed fast-adherent cells, as 
well as cells with delayed adhesion, because the first medium 
change was performed only 5–7 days after inoculation. Other 
researchers report slowly adhering cells (tsai et al., 2004) and 
a mixed population, which was later selected for c-kit expres-
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Fig. 2. The results 
of flow cytometry 
analyses of CD34, 
CD73, HLA-A,B,C 
and HLA-DR,DP,DQ 
expression
Table 2. Flow cytometry analyses of marker expression in AF cells
Marker Flow cytometryа
cD 90 (thy-1) 83% - 58% - 70%
cD 73 (SH3,SH4) 99% - 99% - 96%
СD 105  85% - 89% - n/s
cD 13  99% -  98% - 87%
cD 29 (integrin ß1) 99% -  99% - 99%
cD 44  99%  - 99% - 98%
cD 106 (VcAM-1) - - -
cD 54 (IcAM-1) 43% - 60% - n/s
cD 146  99% -  98% - 90%
cD 71  36%  -  32% - n/s
cD 34 - - -
cD 45 - - -
Keratin 19  92% - 70% - 88%
HLA-A,B,c 95% - 87% - 65%
HLA- Dr,DP,DQ - - -
а This column quotes the percentage of cells positive for this marker in 
the three cultures, respectively; (-)  no expression; and (n/s) was not 
studied .
Table 1. Primers 
Gene Primer sequence
rpl19 5’ agggtacagccaatgcccga 3’
5’ ccttggataaagtcttgatgatc 3’
cD90 5’acctggccatcagcatcgct3’
5’gaaatccgtggcctggagga 3’
β3-tubulin 5’cagtgcggcaaccagatcgg 3’
5’caggtcagcgttgagctggc 3’
nestin 5’ aggaggatgtaccaccagtgc 3’
5’ caccaatgatgtctgcccct 3’
nucleostemin 5’gcatgacctgccataagcgg3’
5’ctgtccactctggacaatggc3’
Pax6 5’ gtcatcaataaacagagttcttc 3’
5’ cgattagaaaaccatacctgtat 3’
Keratin 19 5’gatcgaaggcctgaaggaag3’
5’atgctcagctgtgactgcag3’
p63 5’gagccgtgaattcaacgagg3’
5’tccgaaacttgctgctttctg3’
cD117 (c-kit) 5’gtgggcgacgagattaggctg3’
5’cgcgtttcacacttttgatcatg3’
Oct4 5’cgaccatctgccgctttgag3’
5’ccccctgtcccccattccta3’
nanog 5’gtgtggatccagcttgtccc 3’
5’ctgcgtcacaccattgctattc 3’
rex1 5’gctggagcctgtgtgaacag3’
5’atcacataaggcccacaccg3’
Stella 5’gcctagtgttgtgtcaagac3’
5’ggtgcaagaataagatttatggc3’
Sox2 5’acagcccggaccgcgtcaag 3’
5’tctgcgagctggtcatggag 3’reSeArcH ArtIcLeS
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sion (Delo et al., 2006; De coppi et al., 2007; Perin et al., 2008). 
Some authors suggest that just c-kit positive cells in AF are 
pluripotent. nevertheless, slowly adhering cells are also char-
acterized by a wide range of markers and can differentiate 
into different types of cells.
It has been demonstrated that stem cells isolated from AF 
can undergo 350 population doublings maintaining their un-
differentiated state, high proliferative potential, clonogenic-
ity, and telomere length (Siddiqyi and Atala, 2004; Delo et 
al., 2006; Perin et al., 2008). the maximum number of pas-
sages can reach 42 (Wang et al., 2008). We have obtained three 
cultures from three donors. currently, they have been culti-
vated to  20, 18, and 15 passages. According to a karyological 
analysis performed in a genetic laboratory, the fetuses did not 
exhibit any karyotype abnormality.
PhENOTYPE ChARACTERIzATION ACCORDINg 
TO MOLECuLAR MARkER ExPRESSION 
Flow cytometry shows that cells from AF express the mes-
enchymal markers cD90, cD73, cD105, cD13, cD29, cD44, 
cD146, cD54, and cD71 (weak expression) and do not express 
cD106, cD34, or cD45 (table 2, Fig. 2). these data suggest 
that fetal MScs are present in our cultures.  Judging by flow 
cytometry, the absence of cD34 and cD45 expression shows 
that there are no hemopoietic stem/progenitor cells in the 
culture. these results are in accordance with other authors, 
who report that hemopoietic stem cells are numerous in AF at 
the beginning of pregnancy (7–12 weeks). It seems that these 
cells get there through the thin wall of the yolk sac, where 
hemopoiesis is active at that time (torricelli et al., 1993). At 
the usual time of amniocentesis (16–20 weeks), these cells are 
no longer present in AF (Siddiqyi and Atala, 2004; De coppi 
et al., 2007; Perin et al., 2008; Sessarego et al., 2008). Keratin 19 
was one of the epithelial markers discovered by flow cytom-
etry and immunohistochemistry. Of the antigens of the major 
histocompatibility complex, (MHc), HLA-A,B,c were present 
and HLA-Dr,DP,DQ were not, which is in accordance with 
the expression profiles of MScs and AF cells (In’t Anker et 
al., 2004; tsai et al., 2004; Sessarego et al., 2008; Zheng et al., 
2008). 
Immunohistochemical analysis shows that AF cells ex-
press not only mesenchymal markers such as cD105, StrO-
1, and cD49d, but also neural (neuronal cytoskeleton marker 
β3-tubulin, mature neuron neurofilament nF, and transcrip-
tion factor Pax6) and epithelial markers (keratin 19, tran-
scription factor р63) (table 3, Fig. 3). Keratin 14, which is 
a marker of cornified epidermis, was not found in AF cells. 
notably, more than 70% of the cells express keratin 19, and 
80% also express the mesenchymal cD105 marker, and   
more than 95% express cD73. this suggests that a major 
portion of the cell population can express both mesenchymal 
and epithelial markers  simultaneously. these data must be 
proven by alternative methods. It was demonstrated ear-
lier that AF cell clones can express neural and mesenchy-
mal markers simultaneously (tsai et al., 2006). On the other 
hand, expression of neural markers in MScs is also found 
(corti et al., 2003; Wislet-Gendebien et al., 2004; Bertani et 
al., 2005). However, keratin 19 expression is not character-
а
d e f
b c 100 µm 100 µm 50.0 µm
100 µm 200 µm 200 µm
Fig. 3. Immunohistochemical analyses of mesenchymal, neural and epithelial markers expression in cultured AF cells. Stained with antibodies against (а) 
CD105; (b) CD49d; (c) β3-tubulin; (d) keratin 19; (e) p63; (f) the same field, nuclei stained with DAPI. (а, b, c, d) Merge, nuclei stained with DAPI102 | ActA nAturAe |  № 2 2009
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Fig. 4. Expression of differentiation and stem cell markers determined by RT-PCR
Keratin
stic of mesenchymal cells. thus, our data do not support the 
opinion that AF cells are fetal MScs.  
rt-Pcr data confirm that AF cells express the markers 
of mesenchymal (cD90), neural (β3-tubulin, nestin, nucleo-
stemin, Pax6), and epithelial (keratin 19, p63) lineages (Fig. 
4). Also, rt-Pcr detects the surface marker c-kit, homeo-
box gene Pitx2, and several eScs markers (Oct4, Nanog, and 
Rex-1). these results and previous data (Siddiqyi and Atala, 
2004; tsai et al., 2006; De coppi et al., 2007) suggest a more 
primitive status of amniotic stem cells when compared to 
adult stem cells, as well as their wide differentiation poten-
tial. However, pluripotency markers such as Sox2 and Stella 
were not detectably expressed in AF cells. these data prob-
ably suggest that the potential of the studied cells is less than 
that of eScs, and this might be the reason why AF cells do 
not form teratomas after in vivo transplantation. 
TRANSPLANTATION OF CELLS INTO 
IMMuNODEFICIENT ANIMALS 
teratomas were not observed even 11 weeks after trans-
plantation of cultured human AF cells into immunodeficient 
mice. under the same conditions, human eScs caused ter-
atoma formation after 3–4 weeks. these results are in agree-
ment with data, which show that the in vivo transplantation 
of a large number (up to 8 × 106) of AF cells does not cause 
teratoma formation (De coppi et al., 2007; trounson, 2007). 
Furthermore, it was shown that even seven months after the 
intravenous injection of these cells, experimental animals had 
no detectable tumors  (carraro et al., 2008). 
Animals in the experimental group had no detectable or-
gan abnormalities upon histological examination.
thus, we have obtained cell cultures from three AF donors. 
these cells are characterized by a wide spectrum of marker 
expression, including mesenchymal, neural, epithelial, and 
pluripotency markers. 
taking into account their morphology, cell culture behav-
ior, and expression of multiple mesenchymal cell markers, 
one would assume that AF is a source of MScs which are 
currently being discovered in many tissues (campagnoli et 
al., 2001; Hu et al., 2003; romanov et al., 2003). there is data 
showing that MScs can also express neural markers. On the 
other hand, the data obtained on the expression of epithelial 
markers suggests that the culture may either be heterogene-
ous or that AF cells may have a special differentiation status, 
which seems to be confirmed by the expression of pluripo-
tency markers. We plan to investigate these possibilities in 
the future.
current data on marker expression, differentiation poten-
tial of AF cells, and the absence of teratoma formation af-
Table 3. Immunohistochemistry analyses of marker expression in AF cells
Marker Immunohistochemistry
cD 49d (integrin α4) +
СD 105  +
StrO-1 +
cD 34 -
Pax6 +
nF +
β3-tubulin +
Keratin 19  +
Keratin 14 -
p63 +
(+) marker expression detected; (–) marker expression not detected. 
ter in vivo transplantation leads us to the opinion that these 
cells are promising in the field of cell therapy. We suggest   
that AF cells can be useful for restoring spinal cord damage, 
treating diabetes, Alzheimer’s disease, heart attack dam-
age, etc. (Hampton, 2007). these cells can be used not only 
for autografts, but also for allografts, because the cells are 
only mildly immunogenic and donor-recipient pairs can be 
matched. Also, as opposed to other extraembryonic tissues 
(placenta, amniotic membrane, and umbilical blood) which 
are available only postnatally, AF cells can be obtained at 
16–20 weeks of pregnancy. this suggests the possibility of 
treating developmental defects in utero or immediately after 
birth (Marcus, Woodbury, 2008; Ye et al., 2009).   
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